Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients.

Matteo Megna Elisa CamelaTeresa BattistaLucia GencoFabrizio MartoraMatteo NotoVincenzo PiconeRuggiero AngeloGiuseppe MonfrecolaGabriella Fabbrocini Luca Potestio

Published in: Expert opinion on drug safety (2023)

Our review suggests biologics and small molecules as an effective and safe option for the management of moderate-to-severe forms of psoriasis in elderly patients.

Keyphrases

atopic dermatitis
early onset
high intensity
hip fracture
drug induced
young adults